Navigation Links
Agilent Technologies Signs Agreement to Supply Target Enrichment System to Ambry Genetics for Exome Sequencing
Date:10/27/2011

SANTA CLARA, Calif. and ALISO VIEJO, Calif., Oct. 27, 2011 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) and Ambry Genetics today announced an agreement under which Ambry Genetics will use the Agilent SureSelect Target Enrichment System for exome sequencing services.

(Logo:  http://photos.prnewswire.com/prnh/20110307/LA59848LOGO)

"Ambry is intensely focused on delivering the highest quality results for exome sequencing for all of our clients and customers," said Ardy Arianpour, vice president of Business Development at Ambry Genetics. "With Agilent Technologies we have found the ideal partner we can count on in bringing our exome sequencing to market with scalability and speed. With Agilent's SureSelect, Ambry Genetics is offering whole exome capture services for cancer markers, drug response and Mendelian disease gene discovery. Ambry's exome sequencing services deliver state of the art bioinformatics which include variant filtering, annotation and interpretation of candidate mutations."

"Agilent is very excited to partner with Ambry for their exome sequencing needs," said Kathleen Shelton, Agilent senior marketing director, Genomics. "We believe the quality and consistency SureSelect brings closely complements the level of service provided by Ambry and expected by their customers."

The SureSelect portfolio provides a complete and customizable target enrichment platform. Since it was introduced in 2009, SureSelect has been instrumental in more than 160 published studies covering research into a wide range of heritable disorders and complex diseases. There are now more than 21 products in the SureSelect portfolio, including a full range of catalog and custom products. The SureSelect platform is fully flexible and can be used to enrich targets of interest from less than 20 Kb to more than 100 Mb using eArray, a free online design tool.

About Ambry Genetics

Ambry Genetics is a CAP-accredited and CLIA-certified commercial clinical laboratory with headquarters in Aliso Viejo, Calif. Since the company's inception in 1999, it has become a leader in providing genetic services focused on clinical diagnostics and genomic services, particularly sequencing and array services. Ambry has established a solid reputation for unparalleled service and has been at the forefront of applying new technologies to the clinical molecular diagnostics market and to the advancement of disease research. To learn more about testing and services available through Ambry Genetics, visit www.ambrygen.com.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company's 18,500 employees serve customers in more than 100 countries. Agilent had net revenues of $5.4 billion in fiscal 2010. Information about Agilent is available at www.agilent.com.


'/>"/>
SOURCE Ambry Genetics; Agilent Technologies Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Varian, Inc. Announces Stockholder Approval of Merger Agreement With Agilent Technologies
2. Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays
3. Life Technologies Launches 3500 Dx Series Genetic Analyzers for In Vitro Diagnostic Use in China
4. Life Technologies Announces Third Quarter 2011 Results
5. Reprints Desk and Deep Web Technologies Announce Agreement to Integrate Research Services
6. Synthetic Genomics Inc. and Plenus, S.A. de C.V. Form New Sustainable Agriculture Company, Agradis, Inc. to Develop and Commercialize Products Using Genomic Technologies
7. Omega Protein Announces Retention of Lipid Technologies, LLC
8. Palatin Technologies to Present at 10th Annual BIO Investor Forum
9. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium at International Contract Services Expo
10. Microring device could aid in future optical technologies
11. Life Technologies Announces Flagship PCR Instrument that Enables Cost-Effective, High-Throughput Screening Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... ... 2016 , ... Korean researchers say Manumycin A triggers apoptosis, or natural cell ... treat the disease. Surviving Mesothelioma has just posted an article on the new study. ... based their mesothelioma study on the fact the Manumycin A, a derivative of Streptomyces ...
(Date:5/19/2016)... ... May 19, 2016 , ... ... (CRO) has welcomed Abu Siddiqui as Director, Large Molecule & Biomarker Bioanalysis. , ... vaccine and translational biomarker discovery studies for preclinical and clinical safety programs. “We’ve ...
(Date:5/18/2016)... -- The Biotech industry continues to face a ... are no opportunities ahead. Today, ActiveWallSt.com has on its list ... ), Seattle Genetics Inc. (NASDAQ: SGEN ), Chiasma ... OPHT ). Sign up now to receive our ... Threshold Pharmaceuticals Inc.,s shares gained 0.68%, closing ...
(Date:5/17/2016)... Haselmeier announces the launch by ... by EMA, the European Medicines Agency. Originally launched in ... the new pen version includes enhancements to further improve ... to patients during use. Its enhanced design ... handle with a larger display window that improves the ...
Breaking Biology Technology:
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/22/2016)... , March 22, 2016 ... report "Electronic Sensors Market for Consumer Industry by Type ... Others), Application (Communication & IT, Entertainment, Home ... Global Forecast to 2022", published by MarketsandMarkets, ... expected to reach USD 26.76 Billion by ...
Breaking Biology News(10 mins):